Clinical trial

Repurposing of Dextromethorphan as an Adjunct Therapy in Patients With Major Depressive Disorder

NCT05181527

Study summary

ClinicalTrials.gov

Repurposing of Dextromethorphan as an Adjunct Therapy in Patients With Major Depressive Disorder

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Selective Serotonin Reuptake Inhibitors Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Dextromethorphan Normalized identity: dextromethorphan View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-02-10

PhasePHASE4

Conditions

Major Depressive Disorderverified · MONDO: major depressive disorder

Interventions

Selective Serotonin Reuptake InhibitorsDRUG

DextromethorphanDRUG · verified · RxNorm: dextromethorphan

PlaceboDRUG

Sponsors & collaborators

All India Institute of Medical Sciences, Bhubaneswarlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05181527 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.